Medicine & Life Sciences
Adrenal Cortex Hormones
9%
Allergy and Immunology
16%
Anti-Bacterial Agents
9%
Anti-Idiotypic Antibodies
14%
Antibodies
10%
atezolizumab
13%
Autoantibodies
36%
AZD3965
13%
Biological Phenomena
14%
Body Mass Index
10%
Brain
14%
Brain Neoplasms
28%
Breast Neoplasms
100%
Carcinogenesis
11%
Case-Control Studies
12%
Cell Line
8%
Cell Movement
12%
Circulating Tumor DNA
11%
Clathrin
18%
Complementary DNA
8%
Confined Spaces
24%
Cytokines
11%
Disclosure
33%
DNA Repair
14%
Docetaxel
16%
Double-Stranded DNA Breaks
11%
durvalumab
8%
Dynamins
20%
Embryonic Structures
12%
Emotions
23%
Endocytosis
15%
Endoplasmic Reticulum
14%
Epigenetic Repression
25%
erdafitinib
18%
Estrogen Receptor Modulators
38%
Estrogens
12%
Extracellular Matrix
12%
Fatty Acids
8%
Fulvestrant
19%
Gain of Function Mutation
20%
Genes
14%
Genetic Recombination
14%
Glass
14%
Growth
11%
Heterografts
10%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
14%
Immune Evasion
19%
Immunologic Monitoring
9%
Immunotherapy
60%
Integrins
14%
Interferons
17%
Internet
14%
Lab-On-A-Chip Devices
20%
Lactic Acid
14%
Lapatinib
21%
Letrozole
8%
Ligands
8%
Light
10%
Lighting
16%
lu rong
31%
Lung Neoplasms
8%
MCF-7 Cells
9%
Mechanistic Target of Rapamycin Complex 1
38%
Membranes
9%
Microscopy
12%
Mutation
15%
Myositis
18%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
68%
Neoplasm Metastasis
25%
Neoplasms
81%
Neurons
9%
Non-Small Cell Lung Carcinoma
21%
Null Lymphocytes
19%
Oxidation-Reduction
8%
palbociclib
9%
Phenotype
9%
Phosphatidylinositol 3-Kinases
51%
Progression-Free Survival
8%
Proline
16%
Protein-Arginine N-Methyltransferases
23%
Protein-Tyrosine Kinases
38%
Proteins
8%
Psychological Inhibition
14%
R428 compound
32%
Radiotherapy
10%
Raynaud Disease
19%
Recurrence
10%
ribociclib
16%
RNA Polymerase II
9%
Survival
15%
T-Cell Antigen Receptor
9%
T-Lymphocytes
35%
Therapeutics
32%
Thyroid Gland
28%
Thyrotropin
16%
Triple Negative Breast Neoplasms
18%
Troponin
19%
Troponin I
12%
Vimentin
15%
Weights and Measures
8%